ELV

Business Context and Reporting Period

This summary covers the Form 10-Q filed by Anthem, Inc. (now Elevance Health) for the quarterly period ended June 30, 2003. Anthem is a major health benefits company and an independent licensee of the Blue Cross Blue Shield Association, operating in Indiana, Kentucky, Ohio, Connecticut, New Hampshire, Maine, Colorado, Nevada, and Virginia. As of June 30, 2003, the company served approximately 11.7 million members. The reporting period includes the full impact of the Trigon Healthcare acquisition (completed July 2002), which established the company's Southeast segment.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total operating revenue increased 45% year-over-year, driven primarily by the inclusion of the Trigon acquisition (Southeast segment) and organic growth in premiums and administrative fees.
• Profitability: Net income rose 79% to $369.0 million. Operating gain increased 136% to $530.9 million, reflecting improved underwriting results and favorable prior year reserve developments ($31.7 million net favorable).
• Membership: Total membership grew 41% to 11.7 million. On a "same-store" basis (excluding Trigon), membership increased 10%, driven by gains in National Accounts, Local Large Group, and Individual businesses.
• Cost of Care: The aggregate cost of care trend was approximately 11%, driven by professional services and outpatient costs. The benefit expense ratio improved by 250 basis points to 81.5%.
• Investment Performance: Net realized gains on investments decreased to $3.5 million due to a $23.3 million charge for other-than-temporary impairment of equity securities.

Guidance, Outlook, and Risks

• Cost Trends: Management expects cost of care trends to range from 10.5% to 11.5% through the remainder of 2003.
• Acquisition Status: The pending acquisition of Blue Cross and Blue Shield of Kansas (BCBS-KS) for $190.0 million remains in litigation. The Kansas Supreme Court heard oral arguments in March 2003, but no ruling has been issued.
• Capital Allocation: The company repurchased 1.8 million shares of common stock for $107.8 million during the period. A $500.0 million stock repurchase program remains authorized through February 2005.
• Legal Contingencies: Anthem is involved in various class-action lawsuits regarding provider payments and coverage practices (e.g., Multi-District Litigation in Florida, Connecticut provider suits). The company believes these will not have a material adverse effect, though outcomes are uncertain.
• Regulatory Risk: Ongoing federal reviews of Medicare fiscal intermediary operations and the Federal Employee Program (FEP) could result in fines or penalties, though management does not currently anticipate a material impact.

Investor Verification Checklist

• Reserve Adequacy: Verify the sustainability of the $31.7 million favorable prior year reserve development and the $24.5 million litigation reserve release included in the current period's benefit expense.
• BCBS-KS Acquisition: Monitor the status of the Kansas Supreme Court ruling regarding the $190 million acquisition of BCBS-KS.
• Cost of Care Trends: Track actual medical cost trends against the 10.5%–11.5% guidance, particularly regarding professional services and outpatient utilization.
• Investment Impairments: Review the $23.3 million impairment charge on equity securities and assess potential for future write-downs given market volatility.
• Legal Exposure: Monitor developments in the Multi-District Litigation (MDL) in Florida and Connecticut provider class actions for potential liability.